Medical Research News

Nursing

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wile DJ et al. – Metformin exposure may be an iatrogenic cause for exacerbation of peripheral neuropathy in patients with type 2 diabetes. Interval screening for Cbl deficiency and systemic Cbl therapy should be considered upon initiation of, as well as during, metformin therapy to detect potential secondary causes of worsening peripheral neuropathy.

Related Articles

Prevalence and Risk Factors of Somatic and Autonomic Neuropathy in Prediabetic and Diabetic Patients
Neuroepidemiology, 11/11/09    Relevance Score: 88%

Anti-ganglioside autoantibodies in type 1 diabetes
Muscle & Nerve, 10/08/09    Relevance Score: 87%

Transforming growth factor beta 1 as a biomarker of diabetic peripheral neuropathy: cross-sectional study
Journal of Diabetes and its Complications, 10/12/09    Relevance Score: 82%

Intraepidermal nerve fibre density at wrist level in diabetic and non-diabetic patients
Diabetic Medicine, 11/09/09    Relevance Score: 81%

Sensory and Motor Peripheral Nerve Function and Lower-Extremity Quadriceps Strength: The Health, Aging and Body Composition Study
Journal of the American Geriatrics Society, 10/13/09    Relevance Score: 81%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address